Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Advanced Medical Solutions Group plc    AMS   GB0004536594

Delayed Quote. Delayed  - 10/20 05:35:19 pm
298.75 GBp   -2.13%
09/28 ADVANCED MEDICA : ex-dividend day for interim dividend
09/13 ADVANCED MEDICA : Interim Results
09/08ADVANCED MEDICA : half-yearly earnings release
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201420152016201720182019
Sales63,068,682,693,5102109
EBITDA17,919,922,125,929,131,7
Operating profit (EBIT)15,617,419,523,126,028,4
Pre-Tax Profit (EBT)15,217,019,122,725,527,7
Net income12,914,115,718,020,121,9
P/E ratio20,627,130,035,431,729,1
EPS (GBp )6,086,687,388,439,4110,3
Dividend per Share (GBp )0,700,800,921,061,161,26
Yield0,56%0,44%0,41%0,35%0,39%0,42%
Reference price (GBp )125.25181.25221.75298.75298.75298.75
Announcement Date03/04/2015
07:21am
03/16/2016
07:00am
03/14/2017
07:52am
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201420152016201720182019
Debt------
Finance17,334,251,166,184,197,6
Operating income (EBITDA)17,919,922,125,929,131,7
Leverage
(Debt/EBITDA)
------
Capital Expenditure1,481,911,522,552,401,50
Book Value Per Share (BVPS)44,8 PNC49,6 PNC59,1 PNC68,5 PNC78,0 PNC82,9 PNC
Cash Flow per Share7,83 PNC10,1 PNC9,33 PNC6,10 PNC8,60 PNC9,30 PNC
Announcement Date03/04/2015
07:21am
03/16/2016
07:00am
03/14/2017
07:52am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 634 M GBP -
Entreprise Value (EV) 568 M GBP 550 M GBP
Valuation 2017e 2018e
P/E ratio (Price / EPS) 35,4x 31,7x
Capitalization / Revenue 6,78x 6,22x
EV / Revenue 6,07x 5,40x
EV / EBITDA 21,9x 18,9x
Yield (DPS / Price) 0,35% 0,39%
Price to book (Price / BVPS) 4,36x 3,83x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 24,7% 25,5%
operating Leverage (Delta EBIT / Delta Sales) 1,41x 1,40x
Net Margin (Net Profit / Revenue) 19,2% 19,7%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 12,6% 12,5%
Rate of Dividend 12,5% 12,3%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   2,73% 2,36%
Cash Flow / Sales 13,8% 17,9%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) -2,56x -2,90x
EPS & Dividend